Industry Bulletins | February 5, 2020
LloydsPharmacy Launches Pilot Program To Help & Support Individuals With Mental Health Disorders
LloydsPharmacy is piloting an innovative new service that provides support to individuals who were recently diagnosed with a mental health disorder and prescribed medication. Funded by The National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre (NIHR GM PSTRC), which is a partnership between The University of Manchester and Salford Royal, the pilot is being carried out in ten community pharmacies in Greater Manchester.
The new service, referred to as AMPLIPHY, enables pharmacists to provide personalized support to people who have been newly prescribed a medicine for depression or anxiety. It will also support those who have . . .